CAS 2088247-61-2

SP-8008

CAS: 2088247-61-2

SP-8008 is a monoclonal antibody that inhibits platelet activation. This drug is an antiplatelet agent that prevents the aggregation of platelets and, therefore, reduces the risk of thrombosis. SP-8008 also has an inhibitory effect on collagen-induced platelet activation and does not show any significant side effects in clinical trials. The safety profile for SP-8008 has been demonstrated in a number of animal studies and human clinical trials with no adverse effects on blood coagulation or bleeding time. The molecular modelling study conducted by recombinant murine collagen showed that SP-8008 binds to collagen at a site different from where other antiplatelets such as tirofiban bind. This suggests that SP-8008 may be more effective than tirofiban in preventing vessel occlusion.

Formula: C₂₁H₂₂N₄

Purity: Min. 95%

Molecular weight: 330.4 g/mol

Ref: 3D-NID24761